CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
A Randomized Phase II Study of Durvalumab and Tremelimumab Compared to Doxorubicin in Patients with Advanced or Metastatic Soft Tissue Sarcoma (Medisarc, AIO-STS-0415)
Author
Augustin Marinela
Bauer Sebastian
+12 more
Blocks Andreas
Crysandt Martina
Fischer Marc
Gruenwald Viktor
Hermes Barbara
Hipper Annette
Ivanyi Philipp
Lindner Lars
Pink Daniel
Reichardt Peter
Richter Stephan
Tuchscherer Armin
Publication venue
'S. Karger AG'
Publication date
01/01/2020
Field of study
No full text
Kölner UniversitätsPublikationsServer